---
schema_version: "secwatch.filing_event.v1"
accession: "0001161697-24-000335"
form_type: "8-K"
ticker: "KRMD"
cik: "0000704440"
company_name: "KORU Medical Systems, Inc."
filed_at: "2024-08-07T23:59:59+00:00"
generated_at: "2026-05-31T11:56:54.517226+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# KORU Medical Q2 revenue record $8.4M, up 22%; raises FY2024 guidance

## Summary
- Q2 net revenues of $8.4M, a 22% YoY increase; core business grew 20% driven by SCIg market growth and share gains.
- Gross margin expanded to 65% from 56.1% YoY, a 890bps improvement; gross profit up 41% to $5.5M.
- Net loss improved to $1.0M ($0.02 per share) from $2.5M loss ($0.05 per share) in Q2 2023; adjusted EBITDA loss narrowed to $0.4M.
- Raised FY2024 revenue guidance to $32.0-$32.5M (12-14% growth) and gross margin guidance to 61-62%.
- Cash balance $10.5M; quarterly cash usage $0.3M; reaffirmed cash flow breakeven in Q4 2024 and positive cash in 2025.

## SEC filing metadata
- accession: 0001161697-24-000335
- form_type: 8-K
- ticker: KRMD
- cik: 0000704440
- company_name: KORU Medical Systems, Inc.
- filed_at: 2024-08-07T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/704440/000116169724000335/0001161697-24-000335-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/704440/000116169724000335/form_8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001161697-24-000335
- JSON: https://secwatch.observer/filing/0001161697-24-000335.json
- Plain text: https://secwatch.observer/filing/0001161697-24-000335.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.